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Abstract [261 words] 
Alcohol use disorders (AUD) are common conditions that have enormous social and economic 
consequences. We obtained quantitative measures using the Alcohol Use Disorder 
Identification Test (AUDIT) from two population-based cohorts of European ancestry: UK 
Biobank (UKB; N=121,604) and 23andMe (N=20,328) and performed a genome-wide 
association study (GWAS) meta-analysis. We also performed GWAS for AUDIT items 1-3, 
which focus on consumption (AUDIT-C), and for items 4-10, which focus on the problematic 
consequences of drinking (AUDIT-P). The GWAS meta-analysis of AUDIT total score identified 
10 associated risk loci. Novel associations localized to genes including JCAD and SLC39A13; 
we also replicated previously identified signals in the genes ADH1B, ADH1C, KLB, and GCKR. 
The dimensions of AUDIT showed positive genetic correlations with alcohol consumption 
(rg=0.78-0.98) and Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) alcohol 
dependence (rg=0.33-0.63). AUDIT-P and AUDIT-C showed significantly different patterns of 
association across a number of traits, including psychiatric disorders. AUDIT-P was positively 
genetically correlated with schizophrenia (rg=0.22, p=3.0x10-10), major depressive disorder 
(rg=0.26, p=5.6x10-3), and ADHD (rg=0.23, p=1.1x10-5), whereas AUDIT-C was negatively 
genetically correlated with major depressive disorder (rg=-0.24, p=3.7x10-3) and ADHD (rg=-0.10, 
p=1.8x10-2). We also used the AUDIT data in the UKB to identify thresholds for dichotomizing 
AUDIT total score that optimize genetic correlations with DSM-IV alcohol dependence. Coding 
individuals with AUDIT total score of ≤4 as controls and ≥12 as cases produced a high genetic 
correlation with DSM-IV alcohol dependence (rg=0.82, p=3.2x10-6) while retaining most subjects. 
We conclude that AUDIT scores ascertained in population-based cohorts can be used to 
explore the genetic basis of both alcohol consumption and AUD. 
Introduction 
Alcohol use disorders (AUD) are modestly heritable, with twin-studies demonstrating that 
approximately 50% of the variance is attributed to genetic factors1,2. To date, genetic studies of 
AUD have identified genes that influence pharmacokinetic (e.g. ADH1B, ADH1C, ALDH2)3–8, but 
not pharmacodynamic factors. The difficulty of assembling large, carefully diagnosed cohorts of 
AUD has stimulated additional studies of non-clinical phenotypes, such as alcohol consumption, 
in populations not ascertained for alcohol dependence. This approach has allowed for the 
relatively rapid collection of much larger sample sizes (e.g. >100,000s individuals) and has 
identified numerous loci associated with both pharmacokinetic and pharmacodynamic factors 
that influence alcohol consumption, including ADH1B/ADH1C/ADH59–11, KLB (encoding β-
klotho)10–12 and GCKR, encoding the glucokinase regulatory protein10,11. However, the genetic 
overlap between alcohol consumption (units per week) and DSM-IV diagnosed alcohol 
dependence is moderate (rg = 0.38)13, reinforcing the notion that alcohol consumption cannot be 
used as a surrogate for alcohol dependence or AUD. 
The Alcohol Use Disorders Identification Test (AUDIT) is a screening tool designed to identify 
hazardous alcohol use in the past year14. The test consists of 10 items across 3 dimensions 
pertaining to alcohol consumption (items 1-3, often termed AUDIT-C), dependence symptoms 
(items 4-6), and harmful alcohol use (items 7-10) (collectively AUDIT-P). When the AUDIT was 
developed, a total score of 8 or higher was proposed to be indicative of harmful alcohol use14 
and a score of 20 or higher consistent with a diagnosis of alcohol dependence15; however, there 
is no clear consensus and subsequent studies have suggested that additional factors including 
sex and cultural and social contexts should be considered when deriving thresholds for alcohol 
dependence (reviewed in Supplementary Table 1).  
A recent population-based GWAS of AUDIT in 20,328 research participants from the genetics 
company 23andMe, Inc., identified a locus near the gene ADH1C (rs141973904; p = 4.4 × 
10−7)9 nominally associated with AUDIT total score. AUDIT scores among 23andMe research 
participants were low and predominantly driven by alcohol consumption (AUDIT-C). The genetic 
correlation between AUDIT total score from 23andMe and alcohol consumption was much 
stronger (rg = 0.89, p = 9.01 × 10-10) than the genetic correlation between AUDIT total score and 
alcohol dependence (rg = 0.08; p = 0.65)13.  
In this study, we performed a GWAS meta-analysis using the UK Biobank (UKB; N = 121,604) 
and the previously published 23andMe cohort (N = 20,328)9, yielding the largest GWAS meta-
analysis of AUDIT total score to date (N = 141,932). Using only the UKB cohort, we also sought 
to determine whether the alcohol consumption component of the AUDIT had a genetic 
architecture distinct from the dependence and harmful use components by performing GWASs 
of consumption “AUDIT-C” (items 1-3) and problems “AUDIT-P” (items 4-10). Linkage 
Disequilibrium Score Regression Coefficient (LDSC)16 was used to calculate genetic 
correlations between AUDIT measures and other substance use, psychiatric, and behavioral 
traits. We also calculated genetic correlations with obesity and blood lipid traits, as these have 
previously been shown to associate with alcohol consumption9,10. We hypothesized that AUDIT-
P would correlate more strongly with measures of hazardous substance use, including alcohol 
dependence, and other psychiatric conditions. Finally, in order to determine the thresholds for 
dichotomizing AUDIT total score that would most closely approximate alcohol dependence, we 
converted continuous AUDIT total score into cases and controls using different thresholds, 
performed GWAS on each, and calculated the genetic correlation with DSM-IV alcohol 
dependence13. 
  
Materials and Methods 
UK Biobank sample 
The UK Biobank (UKB) is a population-based sample of 502,629 individuals who were recruited 
from 22 assessment centers across the United Kingdom from 2006-201017. 157,366 individuals 
filled out a mental health questionnaire as part of an online follow-up over a one-year period in 
2017. The Alcohol Use Disorder Identification Test (AUDIT)14 was administered to assess past 
year alcohol use, using gating logic (see Supplementary Figure 1). After performing quality 
control to remove participants with missing data, and keeping only white British unrelated 
individuals, 121,604 individuals with AUDIT total scores were available. AUDIT total score was 
created by taking the sum of items 1-10 for all participants, including those who endorsed 
currently never drinking alcohol (as they could still endorse past alcohol harm on items 9 and 
10). We also created AUDIT subdomain scores by aggregating the scores from items 1-3, which 
include the information pertaining to alcohol consumption (AUDIT-C, N = 121,604), and from 
items 4-10 which indexes the information pertaining to alcohol problems (AUDIT-P, N = 
121,604). These traits were log10 transformed to approximate a normal distribution 
(Supplementary Figure 2). 
 
Genotyping, quality control and imputation 
Genotype imputation was performed on 487,409 individuals by the UKB team using IMPUTE418 
and the Haplotype Reference Consortium reference panel. After quality control, 16,213,998 
SNPs remained for GWAS analyses. Additional details on genotyping and quality control are 
shown in the Supplementary Material.  
 
Discovery GWASs using UKB 
GWAS analyses were performed using BGENIE v1.118 with AUDIT scores (AUDIT total score, 
AUDIT-C, and AUDIT-P, tested independently) as the outcome variable and age, sex, 
genotyping array and 20 principal components of genotype as covariates. See the Life Sciences 
Reporting Summary for extended details. In order to identify independently-associated variants 
(“index variants"), clump-based pruning was applied in FUMA using an r2 of 0.1 and a 1 Mb 
sliding window using the UKB White British sample as the LD reference panel. A 1 Mb window 
was used due to the regions of extended linkage disequilibrium on chromosomes 4q23 and 
17q21.31, which were associated with AUDIT score in this study.  
In addition, we performed a series of 18 case-control GWAS analyses of AUDIT total score 
using different thresholds (cases: ≥8, 10, 12, 15, 18, 20 vs controls: ≤2, 3, 4). The sample size 
at each threshold is shown in Supplementary Table 2. The results of these analyses were 
used to determine which thresholds would produce the greatest genetic correlation with DSM-IV 
defined alcohol dependence13.  
 
SNP-Heritability analyses 
The SNP-heritability of UKB AUDIT scores (total, AUDIT-C, AUDIT-P) was calculated using a 
genomic restricted maximum likelihood (GREML) method implemented in Genetic Complex 
Trait Analysis (GCTA)20 on a subset of 117,072 unrelated individuals using a relatedness cut-off 
of 0.05 and controlling for age and sex. GREML analyses were run using genotyped SNPs with 
a MAF greater than 0.01 to construct the GRM.  
 
GWAS meta-analysis of AUDIT total score using the UKB and 23andMe cohorts 
Because the genetic correlation of AUDIT total score between the UKB and 23andMe cohorts 
was high (rg = 0.77, SE = 0.12, p = 7.15 x 10-11), we performed a sample-size based meta-
analysis of AUDIT total score from the UKB and 23andMe cohorts using METAL (version 2011-
03-25)21. This meta-analysis comprises a total of 141,932 research participants of European 
ancestry and 9,519,872 genetic variants that passed quality control. We used clump-based 
pruning (see ‘Discovery GWAS’) to identify independently-associated variants. For each GWAS 
signal we defined a set of credible variants using a Bayesian refinement method developed by 
Maller et al22. These credible sets are considered to have a 99% probability of containing the 
‘causal’ variant at each locus. Credible set analyses were performed in R 
(https://github.com/hailianghuang/FM-summary) for each of the index variants associated with 
AUDIT score in the GWAS meta-analysis using SNPs within 1Mb with an r2 >0.4 to the index 
variant. All downstream genetic analyses of AUDIT total score were performed using the GWAS 
meta-analysis summary statistics. The 23andMe AUDIT GWAS has previously been published 
(ref) and 30,441 participants from the UKB cohort were included in a previous GWAS of alcohol 
consumption (ref). 
 Functional mapping and annotation of GWAS meta-analysis  
We used FUMA v1.2.823 to study the functional consequences of the index SNPs, and of the 
SNPs contained in each credible set, which included ANNOVAR categories, Combined 
Annotation Dependent Depletion (CADD) scores, RegulomeDB scores, eQTLs, and chromatin 
states. We also studied the regulatory consequences of the index SNPs using the Variant Effect 
Predictor (VEP; Ensembl GRCh37). 
 
Gene-set and pathway analyses  
We performed MAGMA23 competitive gene-set and pathway analyses using the summary 
statistics from the GWAS meta-analysis of AUDIT total score and the AUDIT-C and AUDIT-P 
subsets. SNPs were mapped to 18,546 protein-coding genes from Ensembl build 85. Gene-sets 
were obtained from Msigdb v5.2 (“Curated gene sets”, “GO terms”).  
 
Gene-based association using transcriptomic data with S-PrediXcan 
We used S-PrediXcan24 to predict gene expression levels in 10 brain tissues, and to test 
whether the predicted gene expression correlates with AUDIT scores. We used pre-computed 
tissue weights from the Genotype-Tissue Expression (GTEx v7) project database 
(https://www.gtexportal.org/) as the reference transcriptome dataset. Further details are 
provided in the Supplementary Material.  
 
Genetic correlation analysis 
We used LD Score regression (LDSC) to identify genetic correlations between traits25. This 
method was used to calculate genetic correlations (rg) between AUDIT total score, AUDIT-C, 
and AUDIT-P and 39 other traits and diseases (see Supplementary Tables 3, 4 and 5). We did 
not constrain the intercepts in our analysis, as we could not quantify the exact amount of sample 
overlap between cohorts. We used False Discovery Rate (FDR) to correct for multiple testing26. 
We also used LDSC to examine genetic correlations between various dichotomized versions of 
AUDIT and DSM-IV defined alcohol dependence13. To test for significant differences between 
the genetic correlations, z-score statistics were calculated (see Supplementary Table 6). 
Results 
UKB sample demographics and characteristics  
In the UKB cohort, there were 121,604 individuals with AUDIT scores available for GWAS 
analysis (Supplementary Table 7). The UKB sample was 56.2% female (N = 68,389) and the 
mean age was 56.1 years (S.D. = 7.7). The mean AUDIT total score was 5.0 (S.D. = 4.18, 
range = 0-40); a histogram showing the distribution of the scores is shown in Supplementary 
Figure 2. Over the prior year, 91.9% of the participants reported drinking 1 or 2 drinks on a 
single day. Over the prior year, 6.3% of the participants reported they were not able to stop 
drinking once they started, and 10.7% felt guilt or remorse after drinking alcohol 
(Supplementary Table 7). Males had significantly higher AUDIT total mean scores than 
females (6.09 ± 4.45 vs. 4.15 ± 3.72, respectively; β = 0.47, p < 2 x 10-6; Supplementary 
Figure 3). In addition, age was negatively correlated with AUDIT scores (β = -0.02, p < 2 x 10-6; 
Supplementary Table 8). Therefore, both sex and age were used as covariates in the GWAS 
analyses. The mean AUDIT-C score was 4.24 (S.D. = 2.83) and the mean AUDIT-P score was 
0.75 (S.D. = 2.0). As expected, there was a moderate positive phenotypic correlation between 
AUDIT-C and AUDIT-P (r = 0.478, 95% C.I. = 0.473-0.481, p < 2 x 10-16; Supplementary Table 
8).  
 
SNP-heritability in UKB 
We estimated the SNP-heritability of AUDIT total score to be 12% (GCTA: ± 0.48%, p = 4.6 x 
10-273; LDSC: 8.6% ± 0.50%), which is similar to the estimate from Sanchez-Roige et al.9. The 
SNP-heritability for AUDIT-C was 11% (GCTA: ±0.47%, p = 1.5 x 10-211; LDSC: 8.4% ±0.55%), 
and 9% for AUDIT-P (GCTA: ±0.46%, p = 2.0 x 10-178; LDSC: 5.9% ±0.48%). 
 
GWAS of AUDIT scores in UKB 
The significant results (p < 5 x 10-8) of the GWAS of AUDIT total score in the UKB cohort are 
shown in Supplementary Table 9; this analysis revealed 12 independent GWAS signals 
located in 8 loci. The UKB GWAS of AUDIT-C and AUDIT-P subsets are summarized in 
Supplementary Tables 10 and 11 and Supplementary Figures 4, 16 and 17. Seven of these 
12 independent GWAS signals also significantly associated with AUDIT-C; interestingly, the 
same index variants were identified in the two analyses. An additional GWAS signal was also 
identified close to FNBP4. For AUDIT-P, 5 independent GWAS signals were significantly 
associated and these loci were also associated with the total AUDIT and AUDIT-C. rs1229984 
in ADH1B was not available for meta-analysis in the 23andMe sample and was not in Hardy 
Weinberg equilibrium in the UKB sample used in the present study (p=3.2 x 10-16); however, in 
the total UKB White British sample there was no significant deviation from HWE (p=0.13). The 
association between rs1229984 and AUDIT scores are therefore presented in Supplementary 
Tables 9,10 and 11. rs1229984 was strongly associated with all AUDIT scores in the UKB 
(β=0.04-0.06, p ≤ 1.0 x 10-45) but this SNP was not included for clump-based pruning and 
downstream analyses. As such, a conditional analysis of the SNPs on 4q23 and 4q24 was 
performed in the UKB sample to determine whether any of these associations were significant 
after controlling for rs1229984 genotype. Whilst rs13107325 on 4q24 remained significantly 
associated with AUDIT total score after controlling for rs1229984 genotype, the association 
between rs146788033, rs11733695 and rs3114045 and AUDIT score became attenuated and 
non-significant, suggesting these loci are tagging the strong rs1229984 signal in this region. 
 
GWAS meta-analysis of AUDIT total score 
The GWAS meta-analysis of the UKB and 23andMe samples found 15 independent GWAS 
signals (Supplementary Table 12) associated with AUDIT total score spanning 10 genomic loci 
(Table 1). Figure 1 shows the Manhattan and QQ plots of the GWAS meta-analysis of AUDIT 
total score and Supplementary Figures 5-14 show the regional association plots for the 
independent signals. The inflation factor of the meta-analysis GWAS was λGC = 1.22 with an 
LDSC intercept of 1.008 (SE = 0.007), suggesting that the majority of the inflation is due to 
polygenicity. The 15 independent SNPs show 100% sign concordance for association with 
AUDIT total score across UKB and 23andMe (Table 1); 11 of these SNPs were nominally 
associated with AUDIT total score in 23andMe (p ≤ 0.05), and all index SNPs were associated 
with AUDIT total score in UKB (p < 1.8 x 10-6).  
The top hit for the GWAS meta-analysis of AUDIT total score was a variant (rs11733695) 
located downstream (879 base pairs) from ADH6 (p = 3.4 x 10-30). rs11733695 is in low LD (r2 = 
0.17) with the well-known functional SNP in ADH1B, rs1229984, which is known to alter alcohol 
metabolism27. In addition, two other regions in 4q23 were associated with AUDIT total score in 
the meta-analysis: the index SNPs were located in the ADH1B and ADH1C genes, suggesting 
that there may be independent loci in this region associated with AUDIT scores; however, 
conditional analysis of this region in UKB only suggests that these multiple hits may in fact be 
tagging the rs1229984 signal. This region has been previously associated with alcohol 
consumption, AUD, and AUDIT scores6,7,28,29 
We also replicated the association between KLB (Supplementary Table 12), on chromosome 
4q14, and alcohol consumption10,11,30; the index SNP rs11940694, which is located in the intron 
of KLB, was associated with AUDIT total score in the present study. Credible set analyses 
revealed 7 SNPs at this locus, all located within KLB (Supplementary Table 13). AUDIT total 
score was also associated with SNPs that localized to GCKR on chromosome 2p23.3, which 
has been previously associated with alcohol consumption10,11. Seven SNPs comprised the 
credible set at the GCKR locus, including the missense variant (rs1260326) in GCKR that was 
identified as the index SNP.  
We identified GWAS signals in several regions that have not been previously implicated in the 
genetics of AUD, including 2p21, 17q21, 3q25, 8q22, 10p11, 11p11 and 19q13. The index SNP 
in the 4q24 region is located in an intron of SLC39A8, and the remainder of the credible set for 
this locus, including the missense variant rs13107325, are located in this gene. SLC39A8 is 
highly pleiotropic31 but it is a novel association in relation to alcohol. A region of association on 
2p21 contains 17 SNPs that are localized to the non-coding RNA, LINC01833. A novel region of 
association was also detected on chromosome 10p11.23; this region contains 9 credible SNPs 
that localize to the JCAD (junctional cadherin 5 associated) gene. JCAD encodes an endothelial 
cell junction protein, and has previously been associated with coronary heart disease32. Lastly, 
the index SNP on 19q13.3 is a synonymous variant in FUT2. FUT2 encodes galactoside 2-
alpha-L-fucosyltransferase 2, which controls the expression of ABO blood group antigens. A 
missense SNP in FUT2, rs601338, was strongly associated with susceptibility to diarrhoeal 
episodes33 and this SNP is part of the credible set at this locus.  
The remaining novel associations on 3q25, 8q, 11p11 and 17q21 were more complex. The 
index variants on chromosomes 3q25.33 and 8q22.1 were not localized to any genes, and it is 
unclear from the credible set analyses what the causal variants may be at these loci. The 
credible SNP sets for the 11p11 and 17q21 regions contained over 60 SNPs each, which 
spanned several genes. For example, the index SNP on chromosome 17q21.31 was an intronic 
SNP in MAPT, which encodes the tau protein and has been robustly associated with 
Parkinson’s disease34,35 (Supplementary Table 14) and other neurodegenerative tauopathies36, 
and more recently with neuroticism37. However, we note that the region of association on 
chromosome 17q21.31 spans the corticotrophin receptor gene (CRHR1), which has been 
associated with alcohol use in animals and humans38. Thus, due to the extended complex LD in 
this region, we are unable to determine the likely causal variant. Similarly, the index SNP 
(rs2293576) at chromosome 11p11.2 is a synonymous SNP of the zinc transporter gene 
SLC39A13; however, this region includes 90 associated SNPs, which map to four additional 
genes.  
We used FUMA to functionally annotate all 2,298 SNPs in the credible sets (see 
Supplementary Table 13). The majority of the SNPs were intronic (83.6%; N = 1,922) and 
intergenic (10.5%; N = 240), and only 77 SNPs (4.0%) were exonic. Furthermore, 79 SNPs 
showed CADD scores >12.37, which is the suggested threshold to be considered deleterious39. 
The exonic SNPs (rs492602, rs62062288, rs13135092) of FUT2, MAPT and SLC39A8, 
respectively, had the highest CADD scores (>34), suggesting potential deleterious protein 
effects. 300 SNPs had RegulomeDB scores of 1a-1f, showing evidence of potential regulatory 
effects. 91.0% of the SNPs were in open chromatin regions (minimum chromatin state 1-7).  
 
Gene-based and pathway analyses 
We used MAGMA23 to perform a gene-based association analysis; which identified 40 genes 
that were significantly associated with AUDIT total score (p < 2.7 x 10-6; Supplementary Table 
15, Supplementary Figure 15). As expected, the majority of these genes were in the 10 GWAS 
loci (i.e. KLB, WNT3, RFC1, GCKR, CRHR1); DRD2 was also among the top hits. In addition, 
the analysis revealed a strong burden signal in CADM2 (p = 1.64 x 10-9), where the index 
variant in GWAS meta-analysis did not reach genome-wide significance. We did not identify any 
canonical pathways that were significantly associated with AUDIT (Supplementary Table 16).  
Gene-based (MAGMA) analyses for the AUDIT-C and AUDIT-P subsets (Supplementary 
Figures 16 and 17, respectively) revealed evidence of overlap (Supplementary Figure 18, 
Supplementary Table 17). Two genes (KLB, CADM2) were associated with all 3 AUDIT traits 
(AUDIT total score, AUDIT-C, and AUDIT-P). There was considerable overlap between AUDIT 
total score and AUDIT-C, with 19 overlapping genes associated at the gene-based level. Only 1 
gene, DRD2, was associated with both AUDIT total score and AUDIT-P. 
 
S-PrediXcan 
S-PrediXcan identified a positive correlation (p < 1.07 x 10-6) between AUDIT total score and the 
predicted expression of 27 genes across multiple brain tissues (full results are presented in 
Supplementary Table 18), including MAPT (cerebellum) and FUT2 (caudate and nucleus 
accumbens). SNPs in the region of MAPT and FUT2 were associated with AUDIT total score in 
the GWAS. MAPT (cerebellum) and FUT2 (nucleus accumbens) were also associated with 
AUDIT-C. S-PrediXcan for AUDIT-C and AUDIT-P (Supplementary Tables 19 and 20, 
respectively) revealed lower predicted RFC1 expression in the cerebellar hemisphere was 
associated with both higher AUDIT-C (p = 7.84 x 10-7) and AUDIT-P (p = 1.54 x 10-6) scores. 
    
Genetic correlations 
We used LDSC to evaluate evidence for genetic correlations between our three primary traits 
(AUDIT total score, AUDIT-C, and AUDIT-P) and numerous other traits for which GWAS 
summary statistics were available; these included alcohol and substance use traits, personality 
and behavioral traits, psychiatric disorders, blood lipids, and brain structure volumes 
(Supplementary Tables 3-5 and Figure 2).  
As expected, AUDIT-C and AUDIT-P were highly genetically correlated (rg = 0.70, p = 4.1 x 10-
70). AUDIT scores (AUDIT total score, AUDIT-C, and AUDIT-P) showed strong genetic 
correlations with alcohol consumption from two other studies (rg = 0.76-0.96, p < 2.3 x 10-9). The 
AUDIT-C had a significantly stronger (p = 8.02 x 10-3) correlation with alcohol consumption (rg = 
0.92, p = 7.0 x 10-164) than did AUDIT-P (rg = 0.76, p = 2.7 x 10-52). In contrast, AUDIT total and 
AUDIT-C scores were only modestly correlated with alcohol dependence (rg = 0.39 & 0.33 
respectively, p < 8.2 x 10-5), whereas AUDIT-P showed a nominally stronger genetic correlation 
with alcohol dependence (rg = 0.63, p = 1.8 x 10-8; AUDIT-P vs AUDIT-C, p = 0.033; see 
Supplementary Table 6).  
We detected positive genetic correlations between AUDIT scores (AUDIT total, AUDIT-C, 
AUDIT-P) and other substance use phenotypes, including lifetime smoking (rg = 0.24-0.41, p < 
1.6 x 10-5) and cannabis use (rg = 0.26-0.46, p < 1.1 x 10-4). We also observed a positive genetic 
correlation between AUDIT-P and cigarettes per day (rg = 0.28, p = 4.0 x 10-3). 
Several psychiatric disorders and related traits were positively genetically correlated with 
AUDIT-P scores, including schizophrenia (rg = 0.22, p = 3.0 x 10-10), bipolar disorder (rg = 0.26, 
p = 1.5 x 10-4), ADHD (rg = 0.23, p = 1.1 x 10-5), and major depressive disorder (MDD, rg = 0.26, 
p = 5.6 x 10-3). Intriguingly, AUDIT-C was negatively correlated with MDD (rg = -0.23, p = 3.7 x 
10-3) and ADHD (rg = -0.10, p = 1.8 x 10-2), whereas AUDIT-P showed positive genetic 
correlations with these same disease traits.  
We observed a positive genetic correlation between AUDIT-P scores and depressive symptoms 
(rg = 0.30, p = 3.0 x 10-8) and neuroticism (rg = 0.18, p = 2.6 x 10-4), and a negative genetic 
correlation with subjective well-being (rg = -0.24, p = 4.0 x 10-5). Many of the genetic correlations 
with AUDIT-P were significantly different from the correlations with AUDIT-C (Supplementary 
Table 6).  
We observed positive genetic correlations between AUDIT total score, AUDIT-C and education, 
college attainment, and cognitive ability (rg = 0.19-0.24, p < 1.5 x 10-5). The AUDIT-P genetic 
correlations with the same education and college attainment were near to zero, and were 
significantly lower than AUDIT C and AUDIT total or education traits (Supplementary Table 6). 
There were negative genetic correlations with obesity (rg = -0.16-0.17, p < 1.1 x 10-5), similar to 
previous reports regarding AUDIT total score9 and alcohol consumption10. In contrast, obesity 
was not significantly genetically correlated with AUDIT-P scores (rg = 0.006, p=0.90). Similarly, 
HDL cholesterol and triglycerides were genetically correlated with AUDIT total score and 
AUDIT-C (rg = 0.19-22, p < 9.3 x 10-5, rg = -0.16, p < 1.0 x 10-4 respectively), but this association 
was not found for AUDIT-P (rg = 0.11, p = 2.2 x 10-2, rg = -0.03, p = 6.4 x 10-1). Obesity showed 
significantly different correlations with both AUDIT-P and AUDIT-C (Supplementary Table 6) 
 
Dichotomizing AUDIT total score to more closely approximate alcohol dependence 
As AUDIT can be rapidly ascertained in large populations, we explored methods for 
dichotomizing AUDIT total score that optimized the genetic correlation with DSM-IV alcohol 
dependence13. Higher genetic correlations with alcohol dependence were observed as the 
control threshold was increased from 2 to 4, and with increasingly stringent case cut-offs 
(Figure 3 and Supplementary Table 2). The highest genetic correlation was observed for 
cases with AUDIT total score ≥20 and controls ≤4 (rg = 0.90, SE = 0.25, p = 3.0 x 10-4), 
however, this highly stringent threshold produced very few cases (N=1,290). The standard error 
of the estimate is much larger at more stringent case thresholds and therefore these estimates 
should be interpreted with caution. Defining cases as ≥ 12 yielded an rg of 0.82 (SE = 0.18, p = 
3.2 x 10-6) while retaining more than 7 times as many cases (N=9,130), these genetic 
correlations were not significantly different from those obtained using cases ≥20 and controls ≤4 
(p = 0.80). 
 
 
 
Discussion 
We have presented the largest GWAS meta-analysis of AUDIT total score to date, using large 
population-based cohorts from UKB and 23andMe. We identified novel associations with AUDIT 
total score; the genes located in these regions include JCAD and SLC39A8.  We found 
evidence for association in several loci previously associated with alcohol use via single-variant 
and gene-based analyses (i.e. KLB, GCKR, ADH1B, CADM2). The SNP heritability of all AUDIT 
phenotypes ranged from 9-12% demonstrating that GWAS studies are important to understand 
the genetic component of alcohol use phenotypes. Furthermore, we showed that there is shared 
genetic architecture between AUDIT scores and other alcohol and substance use phenotypes. 
AUDIT-P showed a positive genetic correlation with several psychiatric diseases, distinguishing 
AUDIT-P from AUDIT-C. Finally, using LDSC, we identified thresholds for dichotomizing AUDIT 
total score (AUDIT score ≥12 to define cases, and ≤4 to define controls) that maximize the 
genetic correlation with alcohol dependence while retaining a large number of participants. 
Our top GWAS hits replicated previous association signals for alcohol use traits. The strongest 
associations with AUDIT score in this study spanned the alcohol metabolism genes on 
chromosome 4q2340. Variants in this region were associated with AUDIT total score, AUDIT-C 
and AUDIT-P, demonstrating that alcohol metabolism is a risk factor for both alcohol 
consumption and problematic use. The second strongest signal, also associated with the three 
AUDIT phenotypes, is located in the KLB, confirming the robust association of this gene with 
both alcohol consumption10–12 in humans, and in mice12. However, the biology of this locus could 
be more complex than previously described. Although the credible set analysis suggested that 
the 7 more probable causal variants are all located on the first intron of KLB, one of these 
variants, rs11940694, is an eQTL for RFC1 expression in the brain, and S-PrediXcan analysis 
predicted that lower expression of RFC1 in the cerebellar hemisphere is associated with higher 
predicted AUDIT (AUDIT-C and AUDIT-P) scores. Interestingly, a gene in the complex GWAS 
signal on chromosome 19, FGF21 (Fibroblast growth factor 21), was associated with AUDIT 
(AUDIT total score, AUDIT-C, AUDIT-P) at the gene-based level (Supplementary Table 17). 
Fibroblast growth factor 21 regulates sweet and alcohol preference in mice as part of a receptor 
complex with β-Klotho (KLB) in the central nervous system37. Additionally, we replicated the 
association between a genetic variant (rs1260326) in the gene GCKR and alcohol 
consumption10,11, here associated with AUDIT total score and AUDIT-C. Other loci previously 
associated with alcohol consumption include CADM210, which was associated at the gene-
based level for all three AUDIT traits. Here, the burden analysis suggests that multiple (rare and 
common) variants are necessary to explain the association signal. Intriguingly, several of the 
novel associations with AUDIT scores were mapped to highly pleiotropic genes (MAPT, FUT2, 
SLC39A8)31.  
Genetic analysis of the AUDIT subsets revealed evidence of distinct genetic architecture 
between AUDIT-C and AUDIT-P (alcohol consumption vs. problem use), with support from the 
gene-based (Supplementary Figures 18 and 19), S-PrediXcan, (Supplementary Tables 19 
and 20) and genetic correlation analyses (Figure 2). Furthermore, AUDIT-P showed a strong 
genetic correlation with alcohol dependence13. In contrast, AUDIT-C had a stronger genetic 
correlation with alcohol consumption. Thus, partitioning AUDIT scores into different subsets 
(alcohol consumption vs problem use) may disentangle genetic factors that contribute to 
different aspects of AUD vulnerability.  
Polygenic overlap was observed for all measures of AUDIT and other substance use traits, 
including lifetime tobacco and cannabis use, as we previously reported28,29,43,44, demonstrating 
that genetic risk factors for high AUDIT scores overlap with increased consumption of multiple 
drug types.  
We found several significant differences between the genetic correlations with AUDIT-P and 
AUDIT-C. These differences were particularly pronounced for psychiatric and behavioral traits. 
AUDIT-P was positively genetically correlated with psychopathology (schizophrenia, bipolar 
disorder, MDD, ADHD), personality traits including neuroticism and regional brain volumes. 
These associations have previously been observed at the phenotypic level; AUDs commonly 
co-occur in individuals with schizophrenia45, bipolar disorder46, MDD47 and adults with ADHD48. 
Intriguingly, genetic risk for high AUDIT-C score was negatively correlated with MDD and ADHD 
demonstrating that a distinct genetic component of AUDIT-P is shared with genetic risk for 
psychiatric disease. Regional volume abnormalities in subcortical brain regions of AUD 
individuals have been reported49–51, however, it is unclear whether these alterations are a result 
of high alcohol drinking or a pre-existing vulnerability. We identified a positive genetic correlation 
between AUDIT-P and increased caudate volume; however, the majority of studies report 
reductions in regional brain volumes associated with AUD. 
For AUDIT total score and AUDIT-C we showed positive genetic correlations with educational 
attainment and cognitive ability and negative genetic correlations with obesity, consistent with 
earlier reports9,10. These associations were not observed for AUDIT-P. Similarly, HDL 
cholesterol showed a significant positive correlation, and triglycerides a negative correlation, 
with AUDIT total score and AUDIT-C, but not AUDIT-P. These patterns were previously 
observed for alcohol consumption10. We could speculate that these differences may be linked to 
socioeconomic status (SES). Alcohol consumption is often higher in individuals with higher 
SES52, whereas alcohol-related problems, such as binge drinking53 and alcohol related 
mortality54, are more prevalent in individuals with lower SES. Furthermore, individuals with low 
SES are more likely to have AUDs with psychiatric co-morbidities55. Consistent with this idea, 
we find positive genetic correlations between AUDIT-C and education, a trait correlated with 
SES56, and positive genetic correlations between AUDIT-P and psychopathology. Our findings 
provide further evidence that different dimensions of alcohol use associate differently with 
behavior and that these differences may have a biological underpinning. 
A clinical diagnosis of AUD is often required to define cases for genetic studies. An alternative 
strategy would be to use AUDIT to infer AUD case status; however, it has not been clear 
whether and how to perform meta-analyses between AUDIT scores and alcohol dependence. A 
GWAS meta-analysis for AUDIT and alcohol dependence would be simplified if a threshold 
could be used to define cases and controls based on AUDIT scores, an approach that was used 
by Mbarek et al.57. We have provided empirical evidence about genetic correlations between 
AUDIT and alcohol dependence using dichotomized AUDIT scores, and found thresholds for 
AUDIT that produced high genetic correlations with AUD (Figure 3). Genetic correlations 
increased as the upper threshold was made more stringent, although the standard errors for all 
of these estimates were overlapping. The genetic correlation with alcohol dependence appeared 
to asymptote when case status was defined as ≥12; therefore, this threshold could we used to 
define case status. We also considered various thresholds for defining controls and found that 
≤4 produced a high genetic correlation with alcohol dependence while also retaining the largest 
number of subjects.  
Our study is not without limitations. AUDIT specifically asks about the past year, and thus may 
not capture information on lifetime alcohol use and misuse. This is suboptimal for genetic 
studies because it effectively measures a recent state rather than a stable trait. Measures 
capturing drinking and AUD across the lifespan may be preferable. Also, although mean scores 
for the AUDIT-C dimension were 4.24, the mean of the AUDIT-P dimension was considerably 
lower (0.75). Thus, we were not able to perform a more refined categorization (e.g. 3 subsets: 
consumption [items 1-3], dependence [items 4-6], hazardous use [items 7-10]) as fewer 
individuals endorsed the items comprising AUDIT-P (see Supplementary Table 7, items 9 and 
10). Furthermore, our study uses data from UKB and 23andMe research participants, who were 
volunteers not ascertained for AUD, and hence our findings may not generalize to other 
populations showing higher rates of alcohol use and dependence. Additional alcohol-related 
phenotypes (e.g. age at first use; patterns of alcohol drinking, including binge drinking) could be 
used in subsequent genetic studies to identify additional sources of genetic vulnerability for 
AUD. Lastly, we offered guidelines to identify cases to use in genetic studies of AUD (i.e. AUDIT 
score ≥12); however, these recommendations were based on genetic correlations and may not 
determine thresholds for diagnosing dependence in a clinical setting. Future studies will be able 
to test whether using AUDIT as a surrogate for AUD will be beneficial for gene discovery. In 
addition, several studies have argued that lower thresholds should be used for females, which 
has not been addressed in the present study.  
We have reported the largest GWAS of AUDIT ever undertaken. We replicated previously 
identified signals (i.e. ADH1B/ADH1C; KLB; GCKR), and identified novel GWAS signal (i.e. 
JACD, SLC39A8) associated with AUDIT. We show that different portions of the AUDIT (AUDIT-
C, AUDIT-P) correlate with distinct traits, which will aid in dissecting genetic vulnerability 
towards alcohol use and abuse. The genetic factors that predispose to high alcohol 
consumption inevitably overlap with those for problem drinking, as heavy drinking is generally a 
prerequisite for the development of hazardous use. However, not everyone who consumes 
alcohol experiences the same level of harmful consequences. By studying the different subsets 
of AUDIT, we identify genetic factors that may be specific to problem drinking. Larger studies of 
cohorts with a wider range of AUDIT-P scores are required to both replicate and expand these 
findings. Finally, we describe an alternative strategy to rigorous ascertainment for genetic 
studies of AUD, i.e. AUDIT score ≥12 to define cases and ≤4 to define controls, which could be 
used to achieve large sample sizes in a cost-efficient manner.  
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Figure 1. Manhattan and QQ plots for the SNP-based GWAS meta-analysis of AUDIT total score (N = 141,932) 
 
  
 
 
 
Figure 2. Genetic correlations between the three AUDIT phenotypes (total score, AUDIT-C, AUDIT-P) and several traits measured in 
independent cohorts as described in the Supplementary Tables 3-5: alcohol-related traits, tobacco and cannabis use, 
neuropsychiatric, personality, cognition, anthropomorphic and blood lipids. ADHD, attention-deficit/hyper-activity disorder; BMI, body 
mass index; SE, standard error; IQ, intelligence quotient; HDL, high-density lipoprotein. * p < 0.05, ** p < 0.01, *** p < 0.0001; # 
AUDIT-P vs AUDIT-C, p < 0.01 FDR 5%, (#) AUDIT-P vs AUDIT-C, p < 0.05 
 
Figure 3. Genetic correlations between AUDIT cases (8 [N = 25,423], 10 [N = 15,151], 12 [N = 
9,130], 15 [N = 4,471], 18 [N = 2,099], 20 [N = 1,290]) vs controls (2, 3, 4) in the UK Biobank 
and DSM-IV derived alcohol dependence from the Psychiatric Genetics Consortium. The 
orange line is a visualization of the number of cases used at each threshold, corresponding to 
the N on the right hand y-axis. 
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